HopeStage
Back to all studies
Active Not RecruitingNCT06052137

Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression

Device studyAges 18–80United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 80 years.

Listed locations
StanfordSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 19, 2023
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
16
Sponsor
Stanford University
Sponsor type
University
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 18 Years to 80 Years
Official registry ID
NCT06052137
Official title
Show the full official title

Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression

Recruitment & locations

Not recruiting

Stanford

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Stanford University, a university.

Who can participate?

Listed age limits: 18 years to 80 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies